Experience with intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: Dose considerations

International Journal of Impotence Research

Volumn 23, Issue 4, 2011, Pages 146-150

  Chuang, F P ^a,b   Lakin, M ^a,c   Wu, S T ^b   Cha, T L ^b   Sun, G H ^b   Montague, D K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

erectile dysfunction; intracavernous injection; radical prostatectomy

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; SEXUAL FUNCTION; SYSTEMIC DISEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ALPROSTADIL; DRUG THERAPY, COMBINATION; ERECTILE DYSFUNCTION; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PHENTOLAMINE; PROSTATECTOMY; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 79960400696     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.21     Document Type: Article

References (23)

1. Zippee C, Nandipati K, Agarwal A, Raina R. Sexual dysfunc-tion after pelvic surgery. Int J Impot Res 2006; 18: 1-18.
2. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: result at 10 years. J Urol 1994; 152: 1831-1836. (Pubitemid 24322640)
3. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer1997; 79: 1977-1986.
4. Claro Jde A, de Aboim JE, Maringolo M, Andrade E, Aguiar W, Nogueira M et al. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observa-tional study. Sao Paulo Med J 2001; 119: 135-137.
5. Meuleman EJH, Mulders PFA. Erectile function after radical prostatectomy: a review. Eur Urol 2003; 43: 95-102.
6. Raina R, Lakin MM, Thukral M, Agarwal A, Ausmundsson S, Montaguee DK et al. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostastectomy:SHIM (IIEF-5) analysis. Int J Impot Res 2003; 15: 318-322. (Pubitemid 37376935)
7. Ismail M, Abbott L, Hirsch IH. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose con-siderations and efficacy. Int J Impot Res 1997; 9: 39-42. (Pubitemid 27165904)
8. Blanker MH, Bobnen AM, Groeneveld F, Bernsen R, Prins A, Thomas S et al. for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 46-422.
9. McCullough AR. Rehabilitation of erectile function following radical prostatectomy Asian J Androl 2008; 10: 61-74.
10. Marien T, Sankin A, Lepor H. Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy J Urol 2009; 181: 1817-1822.
11. Ahmed M, Burnett AL. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol 2009; 6: 415-427.
12. Mulhall JP, Bella AJ, Briqanti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010; 7: 1687-1698.
13. Raina R, Lakin MM, Agarwa A, Mascha E, Montague DK, Klein E et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy Urology 2004; 63: 960-966. (Pubitemid 38596687)
14. Zippe CD, Jhaveri FM, Klein EA, Kedia S, Pasqualotto FF, Kedia A et al. Role of viagra after radical prostatectomy Urology 2000; 55: 241-245. (Pubitemid 30069924)
15. Linet OI, Oginc FG. Efficacy and safety of intracavernous alprostadil in men with erectile dysfunction. N Engl J Med 1996; 334: 873-877. (Pubitemid 26107344)
16. Purvis K, Egdetveit I, Christiansen E. Intracavernosal therapy for erectile failure-impact of treatment and reasons for dropout and dissatisfaction. Int J Impot Res 1999; 11: 287-299. (Pubitemid 29505069)
17. Montorsi F, Guazzoni G, Strambi LF, Montorsi F, Da Pozzo LF, Nava L et al. Recovery of spontaneous erectile function after nerve sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trail. J Urol 1997; 158: 1408-1410.
18. Ruiz Rubio JL, Hernandez M, Rivera de los Acros L, Martinez AC, Garcia-Sacristan A, Prieto D. Mechanisms of prostaglan-din E1-induced relaxation in penile resistance arteries. J Urol 2004; 171: 968-973. (Pubitemid 38090543)
19. Lue TF, Broderick GA. Evaluation and nonsurgical manage-ment of erectile dysfunction and premature ejaculation. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell-Walsh Urology 9th edn Saunders Elsevier: Phila-delphia, 2007, pp 750-787.
20. Soli M, Bertaccini A, Carpareli F, Gotti R, Cavrini V, Andrisano V et al. Vasoactive cocktails for erectile dysfunc-tion: chemical stability of PGE1, papaverine and phentola-mine. J Urol 1998; 160: 551-555. (Pubitemid 29476733)
21. Hamid S, Dhabuwala CB, Pontes EJ. Combination intracaver-nous pharmacotherapy in the management of male erectile dysfunction. Int J Impot Res 1992; 4: 109.
22. Montorsi F, Guazzoni G, Bergemaschi F, Ferini SL, Barbieri L, Rigatti P. Four drugs intracavernous therapy for impotence due to corporal veno-occlusive dysfunction. J Urol 1993; 149: 1291-1295. (Pubitemid 23133831)
23. Bannowsky A, Schulze H, Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. J Sex Med 2008; 101: 1279-1283. (Pubitemid 351549634)